TY  - GEN
AU  - Anyanwagu,Uchenna
AU  - Mamza,Jil
AU  - Mehta,Rajnikant
AU  - Donnelly,Richard
AU  - Idris,Iskandar
TI  - Cardiovascular events and all-cause mortality with insulin versus glucagon-like peptide-1 analogue in type 2 diabetes
SN  - 1468-201X
PY  - 2017///0717
KW  - Adult
KW  - Aged
KW  - Biomarkers
KW  - blood
KW  - Blood Glucose
KW  - drug effects
KW  - Cardiovascular Diseases
KW  - diagnosis
KW  - Cause of Death
KW  - Databases, Factual
KW  - Diabetes Mellitus, Type 2
KW  - complications
KW  - Drug Therapy, Combination
KW  - Female
KW  - Glucagon-Like Peptide 1
KW  - adverse effects
KW  - Glycated Hemoglobin
KW  - metabolism
KW  - Humans
KW  - Hypoglycemic Agents
KW  - Insulin
KW  - Kaplan-Meier Estimate
KW  - Male
KW  - Metformin
KW  - therapeutic use
KW  - Middle Aged
KW  - Obesity
KW  - Propensity Score
KW  - Proportional Hazards Models
KW  - Retrospective Studies
KW  - Risk Assessment
KW  - Risk Factors
KW  - Sulfonylurea Compounds
KW  - Time Factors
KW  - Treatment Outcome
KW  - United Kingdom
N1  - Publication Type: Comparative Study; Journal Article; Observational Study
UR  - https://doi.org/10.1136/heartjnl-2015-309164
ER  -